Chr. Hansen and FMC extend product development partnership

Chr. Hansen and FMC Corporation have announced that they will extend their collaborative product development partnership by another five years.

Both companies have been working together to develop and commercialise natural solutions for the biological crop protection industry over the last five years.

This new agreement will see both companies continue to use their resources to develop new products, but will allow both companies to pursue development and commercial opportunities with other parties.

However, the mutual product development pipeline established by the initial partnership will continue to be exclusive, according to a statement from Chr. Hansen.

Christian Barker, Chr. Hansen executive vice-president, Health & Nutrition said: “Chr. Hansen and FMC have enjoyed a successful relationship, including the launch of new products that provide natural alternatives for farmers to significantly boost crop yield.

“Now, with our continued collaboration confirmed, we look forward to launching our strong pipeline of new products together in the years ahead.

“Beyond that pipeline, the new agreement provides full flexibility for both parties which will enable Chr. Hansen to further leverage our distinctive microbial capabilities by also collaborating with additional partners.”

Marc Hullebroeck, president of FMC Europe, Middle East and Africa added: “We are pleased to extend our relationship for at least another five years as we continue to collaborate on commercializing technologies that have been jointly developed.

“In addition, FMC will continue its own efforts on discovery, development and commercialization of new innovative technologies at our state-of-the-art laboratory facilities at FMC’s European Innovation Center near Copenhagen, Denmark.

“Our priority is to focus on differentiated solutions for growers throughout the world.”